Early Study Looks Promising for MS-Like Illness

Posted on October 12th, 2012 by Kelley Luckstein

Mayo Clinic researchers say they were surprised by the success of an early study of a drug to treat a disease often misdiagnosed as multiple sclerosis. "It is very impressive, the results so far,'" said Dr. Sean Pittock, co-director of the clinic's neuroimmunology laboratory. But he cautions the study is preliminary and needs confirmation, bigger numbers and a comparison group.

Additional coverage: DailyFinance, FiercePharma, Hartford Business, American News Report

 

Post-Bulletin by Jeff Hansel

Tags: Dr. Sean Pittock, drug study, multiple sclerosis, neuroimmunology, Post Bulletin, Research

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy